ArticleCancer cell international2022

Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma.

Hilda Samimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.